Citations

Clear

4610 citation(s) found for "Lu, Brian".

Clinical Reasoning: A 55-year-old man with weight loss, ataxia, and foot drop
Flanagan, Eoin P. , Kumar, Neeraj , Krecke, Karl N. , Katz, Brian, Pittock, Sean J. , Leep Hunderfund, Andrea N, Katz, Brian S, Hunderfund, Andrea N. Leep , Murray, Joseph A. , Pittock, S J , Flanagan, E P

Mayo Clinic

Neurology | June 17, 2014 | Volume: 82 | Issue: 24 | Pages: No page available

10.1212/wnl.0000000000000525 | PMID 24960835 Get It

Cystectomy for Refractory Hemorrhagic Cystitis: Contemporary Etiology, Presentation and Outcomes
Linder, Brian J. , Tarrell, Robert F., Boorjian, Stephen A. , Linder, Brian J

Mayo Clinic

Journal of Urology | June 16, 2014 | Volume: 192 | Issue: 6 | Pages: 1687-1692

10.1016/j.juro.2014.06.030 | PMID 24936722 Get It

Active and progressive
Cross, Anne H. , Wingerchuk, Dean M. , Weinshenker, Brian G. , Weinshenker, Brian G

Mayo Clinic

Neurology | June 16, 2014 | Volume: 83 | Issue: 3 | Pages: 206-207

10.1212/wnl.0000000000000601 | PMID 24928117 Get It

Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative
Weiner, Michael W. , Veitch, Dallas P. , Aisen, Paul, Petersen, Ronald C. , Jagust, William, Trojanowski, John Q. , Shaw, Leslie M. , Saykin, Andrew J. , Harvey, Danielle , Pacifico, Anthony, Sheline, Yvette I. , Yaffe, Kristine , Mohlenoff, Brian, Hayes, Jacqueline , Neylan, Thomas C. , Grafman, Jordan Henry , Jack, Clifford R. , Green, Robert C. , Toga, Arthur W. , Friedl, Karl E. , Saykin, Andrew J , Harvey, Danielle J

Mayo Clinic

Alzheimer's & Dementia | June 9, 2014 | Volume: 10 | Issue: 3S | Pages: No page available

10.1016/j.jalz.2014.04.005 | PMID 24924673 Get It

AbstractBoth traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) are common problems resulting from military service, and both have been associated with increased risk of cognitive decline and dementia resulting from Alzheimer's disease (AD) or other causes. This study aims to use imaging techniques and biomarker analysis to determine whether traumatic brain injury (TBI) and/or PTSD resulting from combat or other traumas increase the risk for AD and decrease cognitive reserve in Veteran subjects, after accounting for age. Using military and Department of Veterans Affairs records, 65 Vietnam War veterans with a history of moderate or severe TBI with or without PTSD, 65 with ongoing PTSD without TBI, and 65 control subjects are being enrolled in this study at 19 sites. The study aims to select subject groups that are comparable in age, gender, ethnicity, and education. Subjects with mild cognitive impairment (MCI) or dementia are being excluded. However, a new study just beginning, and similar in size, will study subjects with TBI, subjects with PTSD, and control subjects with MCI. Baseline measurements of cognition, function, blood, and cerebrospinal fluid biomarkers; magnetic resonance images (structural, diffusion tensor, and resting state blood‐level oxygen dependent (BOLD) functional magnetic resonance imaging); and amyloid positron emission tomographic (PET) images with florbetapir are being obtained. One‐year follow‐up measurements will be collected for most of the baseline procedures, with the exception of the lumbar puncture, the PET imaging, and apolipoprotein E genotyping. To date, 19 subjects with TBI only, 46 with PTSD only, and 15 with TBI and PTSD have been recruited and referred to 13 clinics to undergo the study protocol. It is expected that cohorts will be fully recruited by October 2014. This study is a first step toward the design and statistical powering of an AD prevention trial using at‐risk veterans as subjects, and provides the basis for a larger, more comprehensive study of dementia risk factors in veterans.
Anterior spinal artery infarction causing man-in-the-barrel syndrome
Flanagan, Eoin P. , McKeon, Andrew , Weinshenker, Brian G. , Flanagan, E P , McKeon, Andrew

Mayo Clinic

Neurology Clinical Practice | June 9, 2014 | Volume: 4 | Issue: 3 | Pages: 268-269

10.1212/cpj.0000000000000032 | PMID 29473573 Get It

Relapsing inappropriate antidiuretic hormone secretion in an anti-aquaporin-4 antibody positive paediatric patient
Kravljanac, Ružica , Martinović, Vanja, Dujmović, Irena , Djurić, Milena, Weinshenker, Brian G. , Kuzmanovic, Milos B. , Drulovic, Jelena S. , Weinshenker, Brian G

Mayo Clinic

Multiple Sclerosis Journal | May 27, 2014 | Volume: 20 | Issue: 10 | Pages: 1404-1406

10.1177/1352458514536254 | PMID 24866202 Get It

Paediatric patients with the syndrome of an inappropriate antidiuretic hormone secretion (SIADH), as a manifestation of inflammatory demyelinating disorders of the central nervous system, have been rarely described until now, in only a few cases of neuromyelitis optica spectrum disorders (NMOSDs). We present a case of relapsing SIADH associated with NMOSD, in an anti-aquaporin-4 antibody positive 14-year-old girl, who is, to our best knowledge, the first reported paediatric patient with relapsing SIADH and NMOSD. Additionally, our case further supports the notion that paediatric encephalomyelitis associated with SIADH should suggest the diagnosis of NMOSD.
AQP4 autoantibody assay performance in clinical laboratory service
Fryer, J.P. , Lennon, Vanda A. , Pittock, Sean J. , Jenkins, Sarah M. , Fallier‐Becker, Petra, Clardy, Stacey , Horta, Erika , Jedynak, E.A., Lucchinetti, Claudia F. , Shuster, Elizabeth A., Weinshenker, Brian G. , Wingerchuk, Dean M. , McKeon, Andrew , Pittock, S J , Weinshenker, Brian G , McKeon, Andrew , Clardy, Stacey L

Mayo Clinic

Neurology Neuroimmunology & Neuroinflammation | May 23, 2014 | Volume: 1 | Issue: 1 | Pages: No page available

10.1212/nxi.0000000000000011 | PMID 25340055 Get It

Preventive Measures for Patients at Risk for Amputation From Diabetes and Peripheral Arterial Disease
Goodney, Philip P. , McClurg, Asha B. , Stone, David H. , DeMartino, Randall R. , Spangler, Emily L. , Brooke, Benjamin S. , Nolan, Brian W.

Mayo Clinic

Diabetes Care | May 22, 2014 | Volume: 37 | Issue: 6 | Pages: e139-e140

10.2337/dc14-0034 | PMID 24855171 Get It

Specific pattern of gadolinium enhancement in spondylotic myelopathy
Flanagan, Eoin P. , Krecke, Karl N. , Marsh, Richard W., Weinshenker, Brian G. , Giannini, Caterina , Keegan, B. Mark , Flanagan, E P , Weinshenker, Brian G

Mayo Clinic

Annals of Neurology | May 16, 2014 | Volume: 76 | Issue: 1 | Pages: 54-65

10.1002/ana.24184 | PMID 24838831 Get It

Objective To highlight a specific under‐recognized radiological feature of spondylotic myelopathy often resulting in misdiagnosis. Methods Patients evaluated between January 1, 1996 and December 31, 2012 who met the following criteria were included: (1) spondylotic myelopathy was suspected, (2) gadolinium enhancement was detected, and (3) spinal surgery was performed. Results Fifty‐six patients (70% men) whose median age was 53.5 years (range = 24–80) were included. Spinal cord magnetic resonance imaging (cervical in 52; thoracic in 4) revealed longitudinal spindle‐shaped T2‐signal hyperintensity (100%) and cord enlargement (79%) accompanied by a characteristic pancakelike transverse band of gadolinium enhancement in 41 (73%), typically immediately caudal to the site of maximal spinal stenosis. Forty (71%) patients were initially diagnosed with neoplastic or inflammatory myelopathies, and decompressive surgery was delayed by a median of 11 months (range = 1–64). Spinal cord biopsy in 6 did not reveal any alternative diagnosis. Ninety‐five percent were stable or improved. Gadolinium enhancement persisted in 75% at 12 months, raising concern about the accuracy of the initial diagnosis. Twenty patients required a gait aid (36%) at last follow‐up (median = 60 months, range = 10–172). The need for a gait aid preoperatively ( p = 0.005), but not delay of surgery, predicted the need for gait aid at final follow‐up. Interpretation Transverse pancakelike gadolinium enhancement associated with and just caudal to the site of maximal stenosis and at the rostrocaudal midpoint of a spindle‐shaped T2 hyperintensity suggests that spondylosis is the cause of the myelopathy. Persistent enhancement for months to years following decompressive surgery is common. Recognition is important to prevent inappropriate interventions or delay in consideration of a potentially beneficial decompressive surgery. Ann Neurol 2014;76:54–65
The utility of restaging bone marrow biopsy in PET‐negative patients with diffuse large B‐cell lymphoma and baseline bone marrow involvement
Jackson, Amie E., Smeltzer, Jacob P., Jones, Jason M. , Burnette, Brian L., Ristow, Kay M., Wiseman, Gregory A., Macon, William R. , Nowakowski, Grzegorz S. , Habermann, Thomas M. , Witzig, Thomas E.

Mayo Clinic

American Journal of Hematology | May 14, 2014 | Volume: 89 | Issue: 9 | Pages: 865-867

10.1002/ajh.23760 | PMID 24823914 Get It

Patients with diffuse large B‐cell lymphoma (DLBCL) and pre‐treatment bone marrow (BM) involvement require a restaging BM biopsy to document complete remission (CR). We investigated whether BM assessment by restaging PET‐CT could obviate the need for a repeat BM biopsy. Patients with DLBCL and a positive BM biopsy at diagnosis were identified from the Mayo Clinic Lymphoma Data Base. The concordance of BM status on restaging histopathology and PET‐CT reports and the positive (PPV) and negative predictive value (NPV) of PET‐CT were determined. One thousand eighty patients with DLBCL were evaluated and 69 patients (6%) had DLBCL involving the BM at diagnosis. Of 46 patients who completed frontline chemoimmunotherapy, 34 had a restaging PET‐CT and BM biopsy and were included in the analysis. Thirty‐three patients had a negative BM by both PET‐CT and BM biopsy; one patient had persistent BM involvement by biopsy and PET‐CT. Thus, restaging PET‐CT had 100% PPV and 100% NPV for assessing residual BM disease. The findings were validated in a prospective cohort of 68 DLBCL patients treated on a phase II clinical trial where four patients (6%) had DLBCL involving the BM at diagnosis. All had a negative BM by both restaging BM biopsy and PET‐CT. Compared with the gold standard of BM biopsy, PET‐CT had a 100% NPV to exclude residual BM disease after frontline therapy. If further validated, DLBCL practice guidelines and response criteria could be modified so that BM biopsy is no longer required to document CR if the restaging PET‐CT is negative. Am. J. Hematol. 89:865–867, 2014. © 2014 Wiley Periodicals, Inc.